$150,000 of CORMEDIX INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R.____/S.____, Chronic Kidney Disease Improvement in Research and Treatment Act Issues related to patient access to infection prevention."
You can find more data on corporate lobbying on Quiver Quantitative.
CRMD Hedge Fund Activity
We have seen 77 institutional investors add shares of CRMD stock to their portfolio, and 51 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST TURN MANAGEMENT, LLC removed 1,021,421 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $6,291,953
- OBERWEIS ASSET MANAGEMENT INC/ added 485,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,987,600
- J. GOLDMAN & CO LP removed 457,320 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,817,091
- ELLIOTT INVESTMENT MANAGEMENT L.P. removed 426,071 shares (-14.8%) from their portfolio in Q1 2025, for an estimated $2,624,597
- MORGAN STANLEY added 304,891 shares (+76.4%) to their portfolio in Q1 2025, for an estimated $1,878,128
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 295,623 shares (+1106.1%) to their portfolio in Q1 2025, for an estimated $1,821,037
- VANGUARD GROUP INC added 268,360 shares (+7.9%) to their portfolio in Q1 2025, for an estimated $1,653,097
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CRMD Analyst Ratings
Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/30/2025
- Needham issued a "Buy" rating on 06/24/2025
- RBC Capital issued a "Outperform" rating on 06/20/2025
- Leerink Partners issued a "Outperform" rating on 03/07/2025
To track analyst ratings and price targets for CRMD, check out Quiver Quantitative's $CRMD forecast page.
CRMD Price Targets
Multiple analysts have issued price targets for $CRMD recently. We have seen 6 analysts offer price targets for $CRMD in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Brandon Folkes from HC Wainwright & Co. set a target price of $20.0 on 06/30/2025
- Serge Belanger from Needham set a target price of $20.0 on 06/24/2025
- Jason Kolbert from D. Boral Capital set a target price of $15.0 on 06/23/2025
- Leonid Timashev from RBC Capital set a target price of $17.0 on 06/20/2025
- Roanna Ruiz from Leerink Partners set a target price of $18.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
